EMCDDA Mini-European Web Survey on Drugs (EWSD):
Impact of COVID-19 on patterns of drug use, harms and drug services
The findings will contribute to the emerging knowledge base on COVID-19 and Ireland’s response to it, potentially helping to protect the health of people who use drugs and improve drug services. Having access to the EMCDDA findings during the COVID-19 pandemic can help inform our early harm reduction responses to reduce identified harms.
About the survey
The EMCDDA survey looks at the impact of COVID-19 on patterns of drugs use, harm and drug services. It is targeted at people aged over 18 who have used drugs, and structured with modules on:
- COVID-19 status
- Drug using patterns (last 30 days, last year)
- Access to service
- Drug market activity (e.g. changes in the way illicit drugs have been obtained during COVID-19
- The drugs being examined as part of this study are heroin,other opioids, crack, benzodiazepines, MDMA, cannabis, LSD, amphetamines, synthetic cannabinoids and synthetic stimulants.
Please take the time to promote this important survey with your client groups, share the link or promote through afflicted social media channels and networks.